Thomas Zindrick
Amministratore Delegato presso GENELUX CORPORATION
Patrimonio netto: 581 704 $ in data 31/05/2024
Posizioni attive di Thomas Zindrick
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENELUX CORPORATION | Presidente | 01/04/2023 | - |
Amministratore Delegato | 28/05/2014 | - | |
Presidente | 28/05/2014 | - | |
Direttore/Membro del Consiglio | 28/05/2014 | - | |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Direttore/Membro del Consiglio | 16/08/2018 | - |
Storia della carriera di Thomas Zindrick
Precedenti posizioni note di Thomas Zindrick
Società | Posizione | Inizio | Fine |
---|---|---|---|
Amitech Therapeutic Solutions, Inc | Direttore/Membro del Consiglio | 01/01/2011 | 01/02/2021 |
Amministratore Delegato | 01/01/2012 | 01/02/2021 | |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Direttore/Membro del Consiglio | 01/11/2014 | 01/03/2020 |
AMGEN INC. | Responsabile della Conformità | 01/01/2004 | 01/01/2008 |
Corporate Officer/Principal | 01/01/2001 | 01/01/2009 | |
DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - | - |
Formazione di Thomas Zindrick
North Central College | Undergraduate Degree |
University of Illinois College of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
GENELUX CORPORATION | Health Technology |
Aziende private | 4 |
---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
DNX Biopharmaceuticals, Inc.
DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Commercial Services |
Amitech Therapeutic Solutions, Inc |
- Borsa valori
- Insiders
- Thomas Zindrick
- Esperienza